CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cigna (CI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter
Cigna (CI) rated Hold: margins under 2%, cash flow down, and M&A-driven goodwill risks amid U.S. healthcare headwinds.
Greenlight Capital's 13F portfolio rose from $2.85B to $3.19B in Q1 2026, outperforming the S&P 500 with a 6.5% return vs. -4.4%. Read more on the portfolio here.
The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.
Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), is significantly expanding its personalized care management programs through AI-enabled capabilities and predictive analy
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on September 23, 2026, to shareholders of record as of the close of
View interactive chart, options flow, and AI analysis for CI on Zorveq Finance.
Open CI Chart & Analysis →